Race Oncology Company Profile, Contacts & Intelligence

Pharmaceutical ManufacturingAu15 employeesFounded 2016
3 contacts with email or phone data3 with email data
Employees
15
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
3
Mapped contact coverage

Race Oncology Overview

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. Race’s lead asset, bisantrene, is a small molecule chemotherapeutic. Bisantrene has a rich and unique clinical history with demonstrated therapeutic benefits in both adult and paediatric patients, a well characterised safety profile, and compelling clinical data demonstrating an anticancer effect and less cardiotoxicity over certain anthracyclines, such as doxorubicin. Race is advancing a reformulated bisantrene (RC220) to address the high unmet needs of patients across multiple oncology indications, with a clinical focus on anthracycline combinations, where we hope to deliver cardioprotection and enhanced anti-cancer activity in solid tumours. Race is also exploring RC220 as a low intensity treatment for acute myeloid leukaemia. Race is investigating the effect of bisantrene on the m6A RNA pathway, following independent research published by the City of Hope identifying bisantrene as a potent inhibitor of FTO (Fat mass and obesity-associated protein). Dysregulation of the m6A RNA pathway has been described in numerous peer reviewed studies to be a driver of a diverse range of cancers. Race Oncology has collaborated with Astex, City of Hope, MD Anderson, Sheba City of Health, UNC School of Medicine, University of Wollongong and University of Newcastle, and is actively exploring partnerships, licence agreements or a commercial merger and acquisition to accelerate access to bisantrene for patients with cancer across the world. Learn more at www.raceoncology.com.

Headquarters
Au
Industry
Pharmaceutical Manufacturing
Founded
2016
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Race Oncology Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data in the visible sample.
3 departments represented
Visible contacts with email or phone data are mapped to these departments.
3 company-domain emails
Visible contacts using Race Oncology's company email domain.
General
3
Executive
1
Healthcare
1

Race Oncology People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Race Oncology Workforce Composition

Seniority breakdown across 8 visible profiles.

Individual contributor
4
Executive
2
Manager
1
Senior / Lead
1

Race Oncology Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
2

Compare Similar Companies to Race Oncology

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Saxton Group Events Services 124 View company
Clarity Pharmaceuticals Biotechnology Research 65 View company
Imugene Limited Biotechnology Research 36 View company
Paradigm Biopharmaceuticals Pharmaceutical Manufacturing 25 View company
BioNSW Industry Associations 21 View company
Auric Technology, Information And Internet 11 View company
Chimeric Therapeutics Biotechnology Research 10 View company
Adnovate Clinical Biotechnology 8 View company
HaemaLogiX Ltd Biotechnology 7 View company
Island Pharmaceuticals Biotechnology Research 3 View company